股本结构
单位：万股
| 公告日期 | 2025-11-06 | 2025-11-06 | 2025-08-11 | 2025-07-02 | 2025-08-05 | 2025-05-06 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1292.89 | 1273.39 | 1249.89 | 1200.07 | 1070.84 | 1046.23 |
| 普通股本 | 1292.89 | 1273.39 | 1249.89 | 1200.07 | 1070.84 | 1046.23 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-04 | 2025-09-30 | 2025-07-25 | 2025-07-03 | 2025-06-30 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-06 | 1292.89 | 未披露 | 定期报告 | 2025-11-04 |
| 2025-11-06 | 1273.39 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock in connection with July 2025 Offerings, net of issuance costs
Exercise of prefunded warrants
|
2025-09-30 |
| 2025-08-11 | 1249.89 | 未披露 | 定期报告 | 2025-07-25 |
| 2025-07-02 | 1200.07 | 未披露 |
更多>>
Common stock offered by the company 1,538,460 shares of common stock.
|
2025-07-03 |
| 2025-08-05 | 1070.84 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Issuance of common stock under employee benefit plans, net of shares received to settle minimum tax obligation for vesting of restricted stock awards
Cancellation of restricted stock awards
Exercise of pre-funded warrants
|
2025-06-30 |
| 2025-05-06 | 1046.23 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of common stock in connection with March 2025 Offerings, net of issuance costs
|
2025-03-31 |
| 2025-03-31 | 848.78 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of common stock in connection with October 2024 Financings, net of issuance costs
Issuance of shares in connection with 2024 Sales Agreement, net of issuance costs
Issuance of common stock under employee benefit plans, net of shares received to settle minimum tax obligation for vesting of restricted stock awards
Cancellation of restricted stock awards
|
2024-12-31 |
| 2024-11-14 | 846.70 | 未披露 | 定期报告 | 2024-11-11 |
| 2024-10-30 | 837.74 | 未披露 |
更多>>
Common stock offered 2,398,414 shares by the company
|
2024-10-30 |
| 2024-11-14 | 602.03 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Cancellation of restricted stock awards
Issuance of shares in connection with 2024 Sales Agreement, net of issuance costs
|
2024-09-30 |
| 2024-08-01 | 597.89 | 未披露 | 定期报告 | 2024-07-25 |
| 2024-08-01 | 590.43 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock under employee benefit plans, net of shares received to settle minimum tax obligation for vesting of restricted stock awards
Issuance of shares in connection with 2024 Sales Agreement, net of fees of $0.1 million for issuance of shares
|
2024-06-30 |
| 2024-02-08 | 589.41 | 未披露 |
更多>>
From December 31, 2022 to December 31,2023
Issuance of common stock in connection with July Registered Direct, net of fees of $1.3 million
Issuance of common stock under employee benefit plans, including restricted stock awards
Cancellation of restricted stock awards
|
2023-12-31 |
| 2023-12-21 | 589.41 | 未披露 | 定期报告 | 2023-12-18 |
| 2023-11-02 | 588.31 | 未披露 | 定期报告 | 2023-10-26 |
| 2023-11-02 | 588.53 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of shares in connection with July Registered Direct, net of fees of $1.3 million for issuance of shares
Cancellation of restricted stock awards
|
2023-09-30 |
| 2023-09-28 | 588.52 | 未披露 |
更多>>
On September 26, 2023, Curis, Inc. approved a 1-for-20 reverse stock split of the issued and outstanding shares of Common Stock.
|
2023-09-29 |
| 2023-08-03 | 11770.46 | 未披露 | 定期报告 | 2023-07-27 |
| 2023-07-06 | 11775.46 | 未披露 |
更多>>
Common Stock offered by the company 18,409,756 shares
|
2023-07-10 |
| 2023-08-03 | 9934.48 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock under employee benefit plans, including restricted stock awards
|
2023-06-30 |
| 2023-03-13 | 9661.79 | 未披露 |
更多>>
From December 31, 2022 to March 2, 2023
Issuance of common stock under employee benefit plans
|
2023-03-02 |
| 2023-03-13 | 9660.76 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuances of common stock under stock-based compensation plans
Issuance of shares in connection with 2021 Sales Agreement, net of fees of $0.7 million for issuance of shares
|
2022-12-31 |
| 2022-11-09 | 9639.84 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of shares in connection with 2021 Sales Agreement, net of fees of $0.7 million for issuance of shares
|
2022-09-30 |
| 2022-08-04 | 9181.47 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of stock under Employee Stock Purchase Plan
|
2022-06-30 |
| 2022-02-24 | 9164.54 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuances of common stock for purchases under the ESPP
Exercise of stock options
|
2021-12-31 |
| 2021-11-09 | 9160.92 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
|
2021-09-30 |
| 2021-08-03 | 9159.64 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of stock under Employee Stock Purchase Plan
Exercise of stock options
|
2021-06-30 |
| 2021-05-12 | 9153.53 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-05-12 | 9153.43 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Exercise of stock options
|
2021-03-31 |
| 2021-04-14 | 9151.91 | 未披露 | 定期报告 | 2021-03-29 |
| 2021-03-16 | 9150.75 | 未披露 | 定期报告 | 2021-03-12 |
| 2021-03-16 | 9150.25 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Issuance of stock in connection with Aspire Capital Agreement, net of issuance costs
Issuance of shares in connection with Capital on Demand Sales Agreement, net of issuance costs
Issuance of stock under registered direct offering, net of issuance costs
Issuance of common stock under registration statement, net of issuance costs
Exercise of stock options
|
2020-12-31 |
| 2020-12-11 | 8230.51 | 未披露 |
更多>>
1.Common stock offered by the company 25,652,174 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 56,652,885 shares outstanding as of September 30, 2020.
|
2020-12-11 |
| 2020-11-10 | 5881.74 | 未披露 | 定期报告 | 2020-11-03 |
| 2020-11-10 | 5665.29 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of shares in connection with Aspire Capital Agreement
Issuance of shares in connection with Capital on Demand Sales Agreement
|
2020-09-30 |
| 2020-08-04 | 5386.79 | 未披露 | 定期报告 | 2020-07-28 |
| 2020-08-04 | 5063.90 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of stock under Employee Stock Purchase Plan
Exercise of stock options
|
2020-06-30 |
| 2020-06-15 | 5058.23 | 未披露 |
更多>>
1.Common stock offered by us 14,000,000 shares of common stock.
2.The number of shares of our common stock that will be outstanding immediately after this offering as shown above is based on 36,582,309 shares outstanding as of March 31, 2020
|
2020-06-15 |
| 2020-04-22 | 3658.23 | 未披露 | 定期报告 | 2020-04-06 |
| 2020-05-12 | 3658.23 | 未披露 |
更多>>
From December 31, 2019 to March 12, 2020
Issuance of shares in connection with Aspire Capital agreement
|
2020-03-12 |
| 2020-03-19 | 3324.18 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Cancellation of restricted stock awards
|
2019-12-31 |
| 2019-08-09 | 3320.29 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Issuance of stock under the Employee Stock Purchase Plan
|
2019-06-30 |
| 2019-05-14 | 3315.08 | 未披露 |
更多>>
from December 31, 2018 to March 25, 2019
Issuance of common stock, net
|
2019-03-25 |
| 2019-04-11 | 3315.08 | 未披露 | 定期报告 | 2019-01-31 |
| 2019-03-26 | 3315.93 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of stock under grant of restricted stock awards
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Cancellation of restricted stock awards
Retirement of Treasury Stock
|
2018-12-31 |
| 2018-11-01 | 3311.31 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-02 | 3318.11 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-22 | 3312.57 | 未披露 |
更多>>
Curis, Inc. (NASDAQ:CRIS) announced that its Board of Directors approved a 1-for-5 reverse split of Curis's common stock that is expected to take effect on Tuesday, May 29, 2018 after the close of trading.
|
2018-05-30 |
| 2018-03-08 | 16562.84 | 未披露 | 定期报告 | 2018-03-02 |
| 2018-03-08 | 16415.71 | 未披露 |
更多>>
From December 31, 2016 to December 31, 2017
Issuances of common pursuant to sales of shares in the Company’s public offering, net of $0.3 million of issuance costs
Issuances of common pursuant to sales of shares from the Company’s ATM, net of $0.2 million of commissions
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Exercise of stock options settled in shares
|
2017-12-31 |
| 2017-11-07 | 16398.38 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-03 | 14387.90 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-04 | 14377.27 | 未披露 | 定期报告 | 2017-04-26 |
| 2017-05-04 | 14367.72 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-04-04 | 14319.56 | 未披露 | 定期报告 | 2017-03-20 |
| 2017-03-09 | 14188.87 | 未披露 | 定期报告 | 2017-03-02 |
| 2017-03-09 | 14112.40 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Issuance of common stock in consideration for rights granted under the Aurigene collaboration agreement
Issuances of common stock upon the exercise of stock options, and for purchases under the ESPP
|
2016-12-31 |
| 2016-11-03 | 14054.90 | 未披露 | 定期报告 | 2016-10-31 |
| 2016-11-03 | 13999.44 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-04 | 12947.20 | 未披露 | 定期报告 | 2016-07-29 |
| 2016-08-04 | 12946.22 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-09 | 12918.14 | 未披露 | 定期报告 | 2016-05-02 |
| 2016-04-05 | 12903.85 | 未披露 | 定期报告 | 2016-03-21 |
| 2016-02-29 | 12902.20 | 未披露 | 定期报告 | 2016-02-25 |
| 2016-04-05 | 12900.33 | 未披露 | 定期报告 | 2016-01-31 |
| 2016-02-29 | 12899.04 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Issuances of common pursuant to sales of shares in the Company’s public offering , net of $4,380,590 in issuance costs
Issuance of common stock in consideration for rights granted under the Aurigene collaboration agreement
Issuances of common stock upon the exercise of stock options, for purchases under the ESPP
|
2015-12-31 |
| 2015-11-09 | 12839.47 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-06 | 12961.38 | 未披露 | 定期报告 | 2015-08-02 |
| 2015-08-06 | 12839.09 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-07 | 12833.97 | 未披露 | 定期报告 | 2015-05-03 |
| 2015-05-07 | 12833.77 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-04-15 | 12833.57 | 未披露 | 定期报告 | 2015-03-30 |
| 2015-02-24 | 10317.85 | 未披露 | 定期报告 | 2015-02-18 |
| 2015-02-24 | 8603.08 | 未披露 |
更多>>
From December 31, 2013 to December 31, 2014
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
|
2014-12-31 |
| 2014-08-07 | 8600.49 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-03-13 | 8594.81 | 未披露 | 定期报告 | 2014-03-06 |
| 2014-03-13 | 8585.90 | 未披露 |
更多>>
From December 31,2012 to December 31,2013
Issuances of common stock upon the exercise of stock options, for purchases under the ESPP, and pursuant to sales of shares under the Company’s ATM agreement, net of $641,052 in ATM issuance costs
Repurchase of Company common stock
|
2013-12-31 |
| 2013-11-12 | 8579.80 | 未披露 | 定期报告 | 2013-11-04 |
| 2013-11-12 | 8413.02 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-08 | 8169.49 | 未披露 | 定期报告 | 2013-08-01 |
| 2013-07-03 | 8168.39 | 未披露 | 定期报告 | 2013-06-27 |
| 2013-05-09 | 8053.83 | 未披露 | 定期报告 | 2013-05-01 |
| 2013-05-09 | 8015.41 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-03-13 | 8012.20 | 未披露 | 定期报告 | 2013-03-06 |
| 2013-03-13 | 8001.78 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Issuances of common stock upon the exercise of warrants and stock options, for purchases under the ESPP, and pursuant to sales of shares under the Company’s ATM agreement , net of $27,356 in ATM issuance costs and including fair value of warrants exercised of $615,859
Issuance of common stock to licensors
|
2012-12-31 |
| 2012-11-06 | 7996.09 | 未披露 | 定期报告 | 2012-10-30 |
| 2012-11-06 | 7995.07 | 未披露 | 定期报告 | 2012-09-30 |
| 2012-08-09 | 7962.26 | 未披露 | 定期报告 | 2012-08-02 |
| 2012-08-09 | 7953.39 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-10 | 7901.33 | 未披露 | 定期报告 | 2012-05-02 |
| 2012-05-10 | 7868.07 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-02-29 | 7751.24 | 未披露 | 定期报告 | 2012-02-24 |
| 2012-02-29 | 7711.77 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Issuances of common stock upon the exercise of warrants and stock options, for purchases under the ESPP, and pursuant to sales of shares under the Company’s ATM agreement , net of $128,155 in ATM issuance costs
|
2011-12-31 |
| 2011-10-31 | 7658.04 | 未披露 | 定期报告 | 2011-10-27 |
| 2011-10-31 | 7657.57 | 未披露 | 定期报告 | 2011-09-30 |
| 2011-08-04 | 7654.56 | 未披露 | 定期报告 | 2011-07-27 |
| 2011-08-04 | 7648.01 | 未披露 | 定期报告 | 2011-06-30 |
| 2011-04-28 | 7635.00 | 未披露 | 定期报告 | 2011-03-31 |
| 2011-03-08 | 7576.62 | 未披露 | 定期报告 | 2011-03-03 |
| 2011-03-08 | 7575.62 | 未披露 |
更多>>
Issuance of common stock in conjunction with the registered direct offering, net of issuance costs of $1,310,000 and net of fair value of warrants of $2,180,555
Issuances of common stock upon the exercise of warrants
Other issuances of common stock
|
2010-12-31 |
| 2010-10-28 | 7563.87 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-08-03 | 7562.18 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-05-06 | 7561.77 | 未披露 | 定期报告 | 2010-05-03 |
| 2010-05-06 | 7560.02 | 未披露 | 定期报告 | 2010-03-31 |
| 2010-03-03 | 7555.93 | 未披露 | 定期报告 | 2010-02-26 |
| 2010-03-03 | 6731.24 | 未披露 |
更多>>
from December 31, 2008 to December 31, 2009
Issuances of common stock upon the exercise of warrants
Other issuances of common stock
|
2009-12-31 |
| 2009-02-26 | 6365.37 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Issuances of common stock
|
2008-12-31 |
| 2008-03-14 | 6324.11 | 未披露 |
更多>>
from December 31, 2006 to December 31, 2007
Issuance of common stock and warrants, net of issuance costs of $78,000
Other issuances of common stock
Issuance of stock to non-employees for services
|
2007-12-31 |
| 2007-03-02 | 4937.35 | 未披露 | 定期报告 | 2007-02-28 |
| 2007-03-02 | 4933.39 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Issuance of common stock in connection with conversion of note payable to Becton Dickinson
Other issuances of common stock
|
2006-12-31 |
| 2006-03-31 | 4899.63 | 未披露 | 定期报告 | 2006-03-22 |
| 2006-03-31 | 4832.66 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Issuance of common stock in connection with conversion of note payable to Elan Pharma International, Limited
Other issuances of common stock
|
2005-12-31 |
| 2005-03-15 | 4788.01 | 未披露 | 定期报告 | 2005-03-08 |
| 2005-03-15 | 4751.74 | 未披露 |
更多>>
from December 31, 2003 to December 31, 2004
Issuance of common stock and warrants, net of issuance costs of $1,262,000
Issuance of common stock to collaborator
Other issuances of common stock
|
2004-12-31 |
| 2004-03-01 | 4135.91 | 未披露 | 定期报告 | 2004-02-23 |
| 2004-03-01 | 4056.10 | 未披露 |
更多>>
from December 31, 2002 to December 31, 2003
Issuance of common stock in connection with the cancellation of Series A preferred stock and forgiveness of debt
Issuance of common stock and warrants, net of issuance costs of $1,107,000
Issuance of common stock under technology license agreement
Issuance of common stock to collaborator
Other issuances of common stock
Purchase of treasury stock
|
2003-12-31 |
| 2003-03-14 | 3172.08 | 未披露 | 定期报告 | 2003-02-28 |
| 2003-03-14 | 3174.63 | 0.10 |
更多>>
from December 31, 2001 to December 31, 2002
Issuance of restricted common stock for services
Other issuances of common stock
Purchase of treasury stock
|
2002-12-31 |
| 2002-03-29 | 3232.92 | 0.20 |
更多>>
from December 31, 2000 to December 31, 2001
Issuance of common stock, net of issuance costs of approximately $147,000
Other issuances of common stock
Issuance of common stock for license fee
Issuance of common stock as repayment of note payable
|
2001-12-31 |
| 2001-03-30 | 3142.02 | 未披露 | 定期报告 | 2001-03-19 |
| 2001-03-30 | 3138.36 | 未披露 |
更多>>
from December 31, 1999 to December 31, 2000
Issuance of 5.2 million shares of common stock, net of issuance costs of approximately $3.5 million
Issuance of common stock related to the acquisitions of Ontogeny and Reprogenesis
Warrant exercises into common stock
Other issuances of common stock
Exercise of common stock options through issuance of notes receivable
|
2000-12-31 |
From June 30, 2025 to September 30, 2025
Issuance of common stock in connection with July 2025 Offerings, net of issuance costs
Exercise of prefunded warrants
Common stock offered by the company 1,538,460 shares of common stock.
From March 31, 2025 to June 30, 2025
Issuance of common stock under employee benefit plans, net of shares received to settle minimum tax obligation for vesting of restricted stock awards
Cancellation of restricted stock awards
Exercise of pre-funded warrants
From December 31, 2024 to March 31, 2025
Issuance of common stock in connection with March 2025 Offerings, net of issuance costs
From December 31, 2023 to December 31, 2024
Issuance of common stock in connection with October 2024 Financings, net of issuance costs
Issuance of shares in connection with 2024 Sales Agreement, net of issuance costs
Issuance of common stock under employee benefit plans, net of shares received to settle minimum tax obligation for vesting of restricted stock awards
Cancellation of restricted stock awards
Common stock offered 2,398,414 shares by the company
From June 30, 2024 to September 30, 2024
Cancellation of restricted stock awards
Issuance of shares in connection with 2024 Sales Agreement, net of issuance costs
From March 31, 2024 to June 30, 2024
Issuance of common stock under employee benefit plans, net of shares received to settle minimum tax obligation for vesting of restricted stock awards
Issuance of shares in connection with 2024 Sales Agreement, net of fees of $0.1 million for issuance of shares
From December 31, 2022 to December 31,2023
Issuance of common stock in connection with July Registered Direct, net of fees of $1.3 million
Issuance of common stock under employee benefit plans, including restricted stock awards
Cancellation of restricted stock awards
From June 30, 2023 to September 30, 2023
Issuance of shares in connection with July Registered Direct, net of fees of $1.3 million for issuance of shares
Cancellation of restricted stock awards
On September 26, 2023, Curis, Inc. approved a 1-for-20 reverse stock split of the issued and outstanding shares of Common Stock.
Common Stock offered by the company 18,409,756 shares
From March 31, 2023 to June 30, 2023
Issuance of common stock under employee benefit plans, including restricted stock awards
From December 31, 2022 to March 2, 2023
Issuance of common stock under employee benefit plans
From December 31, 2021 to December 31, 2022
Issuances of common stock under stock-based compensation plans
Issuance of shares in connection with 2021 Sales Agreement, net of fees of $0.7 million for issuance of shares
From June 30, 2022 to September 30, 2022
Issuance of shares in connection with 2021 Sales Agreement, net of fees of $0.7 million for issuance of shares
From March 31, 2022 to June 30, 2022
Issuance of stock under Employee Stock Purchase Plan
From December 31, 2020 to December 31, 2021
Issuances of common stock for purchases under the ESPP
Exercise of stock options
From June 30, 2021 to September 30, 2021
Exercise of stock options
From March 31, 2021 to June 30, 2021
Issuance of stock under Employee Stock Purchase Plan
Exercise of stock options
From December 31, 2020 to March 31, 2021
Exercise of stock options
From December 31, 2019 to December 31, 2020
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Issuance of stock in connection with Aspire Capital Agreement, net of issuance costs
Issuance of shares in connection with Capital on Demand Sales Agreement, net of issuance costs
Issuance of stock under registered direct offering, net of issuance costs
Issuance of common stock under registration statement, net of issuance costs
Exercise of stock options
1.Common stock offered by the company 25,652,174 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 56,652,885 shares outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020
Issuance of shares in connection with Aspire Capital Agreement
Issuance of shares in connection with Capital on Demand Sales Agreement
From March 31, 2020 to June 30, 2020
Issuance of stock under Employee Stock Purchase Plan
Exercise of stock options
1.Common stock offered by us 14,000,000 shares of common stock.
2.The number of shares of our common stock that will be outstanding immediately after this offering as shown above is based on 36,582,309 shares outstanding as of March 31, 2020
From December 31, 2019 to March 12, 2020
Issuance of shares in connection with Aspire Capital agreement
from December 31, 2018 to December 31, 2019
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Cancellation of restricted stock awards
From March 31, 2019 to June 30, 2019
Issuance of stock under the Employee Stock Purchase Plan
from December 31, 2018 to March 25, 2019
Issuance of common stock, net
from December 31, 2017 to December 31, 2018
Issuance of stock under grant of restricted stock awards
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Cancellation of restricted stock awards
Retirement of Treasury Stock
Curis, Inc. (NASDAQ:CRIS) announced that its Board of Directors approved a 1-for-5 reverse split of Curis's common stock that is expected to take effect on Tuesday, May 29, 2018 after the close of trading.
From December 31, 2016 to December 31, 2017
Issuances of common pursuant to sales of shares in the Company’s public offering, net of $0.3 million of issuance costs
Issuances of common pursuant to sales of shares from the Company’s ATM, net of $0.2 million of commissions
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
Exercise of stock options settled in shares
From December 31, 2015 to December 31, 2016
Issuance of common stock in consideration for rights granted under the Aurigene collaboration agreement
Issuances of common stock upon the exercise of stock options, and for purchases under the ESPP
From December 31, 2014 to December 31, 2015
Issuances of common pursuant to sales of shares in the Company’s public offering , net of $4,380,590 in issuance costs
Issuance of common stock in consideration for rights granted under the Aurigene collaboration agreement
Issuances of common stock upon the exercise of stock options, for purchases under the ESPP
From December 31, 2013 to December 31, 2014
Issuances of common stock upon the exercise of stock options and for purchases under the ESPP
From December 31,2012 to December 31,2013
Issuances of common stock upon the exercise of stock options, for purchases under the ESPP, and pursuant to sales of shares under the Company’s ATM agreement, net of $641,052 in ATM issuance costs
Repurchase of Company common stock
from December 31, 2011 to December 31, 2012
Issuances of common stock upon the exercise of warrants and stock options, for purchases under the ESPP, and pursuant to sales of shares under the Company’s ATM agreement , net of $27,356 in ATM issuance costs and including fair value of warrants exercised of $615,859
Issuance of common stock to licensors
from December 31, 2010 to December 31, 2011
Issuances of common stock upon the exercise of warrants and stock options, for purchases under the ESPP, and pursuant to sales of shares under the Company’s ATM agreement , net of $128,155 in ATM issuance costs
Issuance of common stock in conjunction with the registered direct offering, net of issuance costs of $1,310,000 and net of fair value of warrants of $2,180,555
Issuances of common stock upon the exercise of warrants
Other issuances of common stock
from December 31, 2008 to December 31, 2009
Issuances of common stock upon the exercise of warrants
Other issuances of common stock
from December 31, 2007 to December 31, 2008
Issuances of common stock
from December 31, 2006 to December 31, 2007
Issuance of common stock and warrants, net of issuance costs of $78,000
Other issuances of common stock
Issuance of stock to non-employees for services
from December 31, 2005 to December 31, 2006
Issuance of common stock in connection with conversion of note payable to Becton Dickinson
Other issuances of common stock
from December 31, 2004 to December 31, 2005
Issuance of common stock in connection with conversion of note payable to Elan Pharma International, Limited
Other issuances of common stock
from December 31, 2003 to December 31, 2004
Issuance of common stock and warrants, net of issuance costs of $1,262,000
Issuance of common stock to collaborator
Other issuances of common stock
from December 31, 2002 to December 31, 2003
Issuance of common stock in connection with the cancellation of Series A preferred stock and forgiveness of debt
Issuance of common stock and warrants, net of issuance costs of $1,107,000
Issuance of common stock under technology license agreement
Issuance of common stock to collaborator
Other issuances of common stock
Purchase of treasury stock
from December 31, 2001 to December 31, 2002
Issuance of restricted common stock for services
Other issuances of common stock
Purchase of treasury stock
from December 31, 2000 to December 31, 2001
Issuance of common stock, net of issuance costs of approximately $147,000
Other issuances of common stock
Issuance of common stock for license fee
Issuance of common stock as repayment of note payable
from December 31, 1999 to December 31, 2000
Issuance of 5.2 million shares of common stock, net of issuance costs of approximately $3.5 million
Issuance of common stock related to the acquisitions of Ontogeny and Reprogenesis
Warrant exercises into common stock
Other issuances of common stock
Exercise of common stock options through issuance of notes receivable